ERBCX
Price
$19.40
Change
-$0.02 (-0.10%)
Updated
Aug 15 closing price
Net Assets
633.99M
RWBEX
Price
$72.43
Change
+$0.05 (+0.07%)
Updated
Aug 15 closing price
Net Assets
137.49B
Interact to see
Advertisement

ERBCX vs RWBEX

Header iconERBCX vs RWBEX Comparison
Open Charts ERBCX vs RWBEXBanner chart's image
Eaton Vance RBA Equity Strategy Fd Cl C
Price$19.40
Change-$0.02 (-0.10%)
VolumeN/A
Net Assets633.99M
American Funds Capital World Gr&Inc R2E
Price$72.43
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets137.49B
ERBCX vs RWBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ERBCX vs. RWBEX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERBCX is a Buy and RWBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWBEX has more cash in the bank: 137B vs. ERBCX (634M). RWBEX pays higher dividends than ERBCX: RWBEX (1.06) vs ERBCX (0.00). ERBCX was incepted earlier than RWBEX: ERBCX (15 years) vs RWBEX (11 years). ERBCX (2.05) is less costly to investors than RWBEX (1.21). ERBCX is a more actively managed with annual turnover of: 35.00 vs. RWBEX (27.00). RWBEX has a lower initial minimum investment than ERBCX: RWBEX (250) vs ERBCX (1000). RWBEX annual gain was more profitable for investors over the last year : 10.91 vs. ERBCX (8.26). RWBEX return over 5 years is better than : 45.19 vs. ERBCX (15.37).
ERBCXRWBEXERBCX / RWBEX
Total Expense Ratio2.051.21169%
Annual Report Gross Expense Ratio2.051.21169%
Fund Existence15 years11 years-
Gain YTD9.66615.15164%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets634M137B0%
Annual Yield % from dividends0.001.06-
Returns for 1 year8.2610.9176%
Returns for 3 years13.9239.6235%
Returns for 5 years15.3745.1934%
Returns for 10 years34.3861.3456%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP13.972.49
+21.69%
Coeptis Therapeutics Holdings Inc
GTLB44.283.33
+8.13%
GitLab
ARDX5.970.13
+2.23%
Ardelyx
DMAC6.030.02
+0.33%
DiaMedica Therapeutics
BTSGU78.68-0.04
-0.05%
BrightSpring Health Services